etrolizumab
roche
['crohn', 'ibd']
vermeire - etrolizumab (anti-beta7) disappointing results in #crohnsdisease but heavily impacted by very high pbo response rates during both induction &amp; maintenance (not clear why). safety signal very reassuring #uegweek22 #ibd
Swedish physician specializing in the treatment of Crohn's disease and Ulcerative Colitis. Views - my own.